EBITDA up 16% to $205mill
reported NPAT substaintally up to $185Mill up 65%
adjusted EPS FY18 54 cents vs FY17 49.4 cents up 10%
current p/e is 32%
average # of shares 242,371
ROE around 60% efficient
good Revenue form both Asia via Encar and Latin America
but
EBITDA
Asia whooping big start here..
Latin America - Growth in Chile ok ...Mexico and Argentina not managed here!!!! so if they pick up the game here will be good 2019
- Forums
- ASX - By Stock
- CAR
- Ann: FY18 Results Presentation
Ann: FY18 Results Presentation, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAR (ASX) to my watchlist
|
|||||
Last
$33.72 |
Change
-0.650(1.89%) |
Mkt cap ! $12.79B |
Open | High | Low | Value | Volume |
$34.28 | $34.39 | $33.65 | $15.11M | 446.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 1030 | $33.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$33.73 | 479 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 143 | 33.700 |
13 | 618 | 33.690 |
5 | 163 | 33.680 |
8 | 525 | 33.670 |
4 | 133 | 33.660 |
Price($) | Vol. | No. |
---|---|---|
33.710 | 593 | 18 |
33.720 | 80 | 2 |
33.730 | 309 | 4 |
33.740 | 209 | 4 |
33.750 | 102 | 2 |
Last trade - 15.52pm 03/07/2024 (20 minute delay) ? |
Featured News
CAR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online